As has so often been the New Zealand way, when one mainstay exits the stage, another takes to the boards without a mis-step.
Many people living with a "serious mental illness" are perfectly sane and honest human beings, and some people without a MI diagnosis are irrational liars who are out of touch with reality.
Standard life table analysis was used to calculate the person-years of life gained without an MI or stroke, based on estimates of the incidence of these disorders in England and Wales.
Under the holistic model, 33%% of people who take the polypill from age 50 benefit, gaining, on average, 8 years of life without an MI or stroke (19%% and 14 years under the reductionist model).
After adjustment for multiple baseline risk factors, patients with a history of MI without diabetes at baseline had a 1.9 times greater likelihood of fatal CHD or nonfatal MI, compared with diabetic patients without a prior MI.
As secondary prevention treatment is known to be different for patients with COPD compared with non-COPD patients, only using first MIs allowed us to assess the effect of COPD on mortality after an MI without bias due to differences in previous treatment.
The proportion of individuals who benefit was taken as everyone who would, without treatment, have an MI or stroke (holistic model), rather than limiting the benefit to the proportion calculated from the relative risk reduction (reductionist model), as is current practice.
A further limitation of our study is that we have not distinguished in our interviews between new onset depression post MI which has been found to affect cardiac outcome [ 24] and other depression because we have recruited from a heterogenous group of patients who may have been on the CHD registers for many years after an MI or who may have evidence of CHD without having had an MI.
To identify genetic polymorphisms associated with MI, we interrogated three case control studies comprising cases with a history of MI and controls without a history of MI.
A total of 711 subjects, including 351 subjects with first-time acute MI and 360 subjects without a history of MI were genotyped for Arg IRS-1 polymorphism.
In an observational study in Finland, the prevalence of myocardial infarction (MI) in T2DM patients without a history of MI and in non-T2DM patients with a history of MI was similar (20.2 and 18.8 %, respectively) [ 2].
